Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
PRME on Nasdaq
ARCH Venture Partners XII, LLC - trading volume in the past year for Prime Medicine, Inc.
Holdings reported by ARCH Venture Partners XII, LLC for Prime Medicine, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
6.13M |
$38.3M |
$6.25 |
Feb 15, 2024 |
By ARCH Venture Fund X, L.P. |
|
|
| Common Stock |
6.13M |
$38.3M |
$6.25 |
Feb 15, 2024 |
By ARCH Venture Fund X Overage, L.P. |
|
|
| Common Stock |
3.2M |
$20M |
$6.25 |
Feb 15, 2024 |
By ARCH Venture Fund XII, L.P. |
|
|
Transactions reported by ARCH Venture Partners XII, LLC for Prime Medicine, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.